The heavily criticized Medicare two-midnights rule involving short inpatient stays has technically been in effect for the past year.
The heavily criticized
involving short inpatient stays has technically been in effect for the past year. But providers, regulators and healthcare observers are not sure the rule will hold up in its current makeshift form.
The two-midnights rule entered the healthcare vernacular last year after it was finalized in Medicare's fiscal 2014 inpatient rule. But enforcement and details of the rule have been far from concrete since then. “It's just been a lot of change and a lot of confusion for hospitals,” said Regan Tankersley, a healthcare attorney with Hall, Render, Killian, Heath & Lyman.
Source: ModernHealthcare
Read the full story:
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More